596-51-0
596-51-0
Chemical Structure
Glycopyrrolate
Synonym(s): Glycopyrronium bromide; Glycopyrrolate bromide
- CAS No.: 596-51-0
- Formula:C19H28BrNO3
- Molecular Weight:398.33
IUPAC Name: 3-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide
InChIKey: VPNYRYCIDCJBOM-UHFFFAOYSA-M
SMILES: C[N+]1(C)CC(OC(C(O)(C2CCCC2)C3=CC=CC=C3)=O)CC1.[Br-]
Biological Activity: Glycopyrrolate (Glycopyrronium bromide), a quaternary ammonium derivative, is a muscarinic receptor antagonist. Glycopyrrolate has bronchoprotective effect and produces a beneficial effect on blood pressure. Glycopyrrolate can be used for the research of bronchial diseases[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Glycopyrrolate | 99.93% | Glycopyrrolate (Glycopyrronium bromide), a quaternary ammonium derivative, is a muscarinic receptor antagonist. Glycopyrrolate has bronchoprotective effect and produces a beneficial effect on blood pressure. Glycopyrrolate can be used for the research of bronchial diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycopyrrolate (Standard) | ≥98% | Glycopyrrolate (Standard) is the analytical standard of Glycopyrrolate. This product is intended for research and analytical applications. Glycopyrrolate (Glycopyrronium bromide), a quaternary ammonium derivative, is a muscarinic receptor antagonist. Glycopyrrolate has bronchoprotective effect and produces a beneficial effect on blood pressure. Glycopyrrolate can be used for the research of bronchial diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycopyrrolate-d3 bromide | 99.63% | Glycopyrrolate-d3 (bromide) is deuterium labeled Glycopyrrolate. Glycopyrrolate (Glycopyrronium bromide), a quaternary ammonium derivative, is a muscarinic receptor antagonist. Glycopyrrolate has bronchoprotective effect and produces a beneficial effect on blood pressure. Glycopyrrolate can be used for the research of bronchial diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycopyrrolate-d5 bromide | 99.37% | Glycopyrrolate-d5 (bromide) is deuterium labeled Glycopyrrolate. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Sofpironium bromide (Standard) | ≥98% | Sofpironium bromide (Standard) is the analytical standard of Sofpironium (bromide) (HY-109013). This product is intended for research and analytical applications. Sofpironium bromide (BBI 4000) is an anticholinergic agent used in the study of primary axillary hyperhidrosis (PAH). Sofpironium bromide reduces sweating by inhibiting M3 muscarinic receptors in eccrine glands at the application site. Sofpironium bromide also has a high afnity for the M1, M2, M4 and M5 subtypes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycopyrronium impurity 2 | Glycopyrronium impurity 2 is an impurity of Glycopyrronium. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(R,R)-Glycopyrrolate | (R,R)-Glycopyrrolate ((R,R)-Glycopyrronium (bromide); (R,R)-Glycopyrrolate (bromide)) is an anticholinergic agent. (R,R)-Glycopyrrolate ((R,R)-Glycopyrronium (bromide); (R,R)-Glycopyrrolate (bromide)) has the ability to reduce the frequency of drooling in vivo with developmental disabilities. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycopyrronium impurity 6 | Glycopyrronium impurity 6 is an impurity of Glycopyrronium. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycopyrronium impurity 4 (Standard) | ≥98% | Glycopyrronium impurity 4 (Standard) is the analytical standard of Glycopyrronium impurity 4. This product is intended for research and analytical applications. Glycopyrronium impurity 4 is an impurity of Glycopyrronium. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Methyl 2-cyclohexyl-2-hydroxyphenylacetate | Methyl 2-cyclohexyl-2-hydroxyphenylacetate is a biochemical reagent. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycopyrrolate impurity 3 | Glycopyrrolate impurity 3 is an impurity of Glycopyrrolate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Glycopyrrolate impurity 1 bromide | Glycopyrrolate impurity 1 bromide is an impurity of Glycopyrrolate bromide. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dehydro glycopyrrolate bromide | Dehydro glycopyrrolate bromide (Glycopyrrolate impurity 2) is an impurity of Dehydro glycopyrrolate bromide. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
rel-(R,R)-Glycopyrrolate | rel-R,R-Glycopyrrolate (rel-(R,R)-Glycopyrronium bromide) is a drug impurity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Maarsingh H, et al. Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction [J]. Cells, 2021, 10(5): 1237. [Content Brief]
- [2]. Dyson D H, et al. Dose effect and benefits of glycopyrrolate in the treatment of bradycardia in anesthetized dogs [J]. The Canadian Veterinary Journal, 1999, 40(5): 327. [Content Brief]
- [3]. Hansel T T, Neighbour H, Erin E M, et al. Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma [J]. Chest, 2005, 128(4): 1974-1979. [Content Brief]
